NCT05285306

Brief Summary

The purpose of this study is to test the feasibility and acceptability of a brief coping skills training program addressing anxiety and pain related to surveillance pelvic examinations for female gynecologic cancer survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 7, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 17, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

March 21, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2022

Completed
Last Updated

May 11, 2023

Status Verified

November 1, 2021

Enrollment Period

6 months

First QC Date

March 7, 2022

Last Update Submit

May 10, 2023

Conditions

Outcome Measures

Primary Outcomes (8)

  • Intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R)

    The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).

    post pelvic examination (approximately 2-3 months after baseline)

  • Change in intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R)

    Change in intervention acceptability from immediately after completion of the 3 sessions (post intervention assessment) to after trying to implement the coping skills during their next pelvic examination (post pelvic exam assessment), using the STTS-R. The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).

    post-intervention (within 2 weeks of their next pelvic examination), post pelvic examination (approximately 2-3 months after baseline)

  • Intervention feasibility as measured by percentage of recruited participants who enrolled

    Enrollment logs will capture the number of participants who were recruited and among them, the number that enrolled in the study.

    post pelvic examination (approximately 2-3 months after baseline)

  • Intervention feasibility as measured by attrition

    Retention logs will capture the number of participants who did not complete the study protocol (rate of attrition)

    post pelvic examination (approximately 2-3 months after baseline)

  • Intervention feasibility as measured by survey completion

    Retention logs will capture the number of participants who completed all assessments

    post pelvic examination (approximately 2-3 months after baseline)

  • Intervention feasibility as measured by home practice completion

    Interventionist logs completed at the conclusion of each session will capture the level of home practice completion

    post-intervention (within 2 weeks of their next pelvic examination)

  • Intervention feasibility as measured by participant engagement

    Interventionist logs completed at the conclusion of each session will capture the level of participant engagement with a 1 item question rated from 1 (not at all engaged) to 4 (highly engaged).

    post-intervention (within 2 weeks of their next pelvic examination)

  • Intervention feasibility as measured by interventionist fidelity

    Fidelity rating forms will be used to measure the level of fidelity to session content for one third of the sessions for the protocol. Each component of the session will be rated from 0 (not covered at all) to 3 (thoroughly covered the topic)

    post-intervention (within 2 weeks of their next pelvic examination)

Secondary Outcomes (2)

  • Change in anxiety related to examination as measured by the The State Anxiety Scale of the State-Trait Anxiety Inventory

    baseline, post-intervention (within 2 weeks of their next pelvic examination), post pelvic examination (approximately 2-3 months after baseline)

  • Change in pain during examination as measured by numeric scales

    baseline, post pelvic examination (approximately 2-3 months after baseline)

Study Arms (1)

PEACE Program

EXPERIMENTAL

3 sessions of tailored coping skills related to pelvic examinations

Behavioral: PEACE Program

Interventions

PEACE ProgramBEHAVIORAL

This pilot will consist of 3 individual telemedicine sessions to teach cognitive behavioral coping skills and provide education related to gynecologic cancer surveillance and psychological distress.

Also known as: Pelvic Exam and Anxiety Coping Skills for Empowerment
PEACE Program

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female sex
  • diagnosis of stage I-IV cervical or endometrial cancer
  • years of age or older
  • able to speak/read English
  • able to give informed consent
  • completed cancer treatments within 2-24 months prior to enrollment, and recommended to undergo surveillance pelvic examination at three month intervals
  • able to commit to three 45-60 minute visits within the study period
  • able to participate in the intervention via the telemedicine modality (e.g., phone or video)

You may not qualify if:

  • unable to provide informed consent
  • major untreated or uncontrolled mental illness
  • hearing impairment that impedes telephone or video calls

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27705, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Rebecca Shelby, PhD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2022

First Posted

March 17, 2022

Study Start

March 21, 2022

Primary Completion

September 2, 2022

Study Completion

September 2, 2022

Last Updated

May 11, 2023

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations